JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2008) 198, 271-279       DOI: 10.1677/JOE-08-0063
© 2008 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary figures
Right arrow All Versions of this Article:
JOE-08-0063v1
198/2/271    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Artner, I.
Right arrow Articles by Stein, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Artner, I.
Right arrow Articles by Stein, R.

MafA is a dedicated activator of the insulin gene in vivo

Isabella Artner1, Yan Hang1, Min Guo1, Guoqiang Gu2 and Roland Stein1,2

Departments of1 , Molecular Physiology and Biophysics2 Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37205, USA

(Correspondence should be addressed to I Artner who is now at Developmental Biology Program, Stem Cell Center, Lund University, Lund 22184, Sweden; Email: isabella.artner{at}med.lu.se)

As successful generation of insulin-producing cells could be used for diabetes treatment, a concerted effort is being made to understand the molecular programs underlying islet β-cell formation and function. The closely related MafA and MafB transcription factors are both key mammalian β-cell regulators. MafA and MafB are co-expressed in insulin+β-cells during embryogenesis, while in the adult pancreas only MafA is produced in β-cells and MafB in glucagon+{alpha}-cells. MafB–/– animals are also deficient in insulin+ and glucagon+ cell production during embryogenesis. However, only MafA over-expression selectively induced endogenous Insulin mRNA production in cell line-based assays, while MafB specifically promoted Glucagon expression. Here, we analyzed whether these factors were sufficient to induce insulin+ and/or glucagon+ cell formation within embryonic endoderm using the chick in ovo electroporation assay. Ectopic expression of MafA, but not MafB, promoted Insulin production; however, neither MafA nor MafB were capable of inducing Glucagon. Co-electroporation of MafA with the Ngn3 transcription factor resulted in the development of more organized cell clusters containing both insulin- and glucagon-producing cells. Analysis of chimeric proteins of MafA and MafB demonstrated that chick Insulin activation depended on sequences within the MafA C-terminal DNA-binding domain. MafA was also bound to Insulin and Glucagon transcriptional control sequences in mouse embryonic pancreas and β-cell lines. Collectively, these results demonstrate a unique ability for MafA to independently activate Insulin transcription.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Endocrinology.